Skip to content

Clinical trials

Completed Phase 2 Diabetic Nephropathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Phase: Phase 2 Status: Completed Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20041
20052
20065
20072
20082
20093
20105
20118
20127
20134
20143
20154
20161
20171
20184
20194
20204
20212
20224
20234
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed76

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie (prior sponsor, Abbott)4
Tanabe Pharma Corporation4
AstraZeneca3
Bayer3
Biogen3
Pfizer3
Amgen2
BioStratum2
Gilead Sciences2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies76
Diabetes Mellitus, Type 216
Renal Insufficiency, Chronic15
Diabetes Mellitus10
Proteinuria10
Albuminuria7
Hypertension7
Kidney Diseases7
Diabetes Complications4
Diabetes Mellitus, Type 12

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.